Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Nutritional predictors of lymphatic filariasis progression: Insights from a machine learning approach

Amewu EKA, Amaglo B, Osei-Poku P, et al. Public Library of Science (PLoS). PLOS ONE. 2025;
Download PDF
Publication

Adopting telehealth service for lymphedema care: Insights from a Filariasis Management Clinic, Puducherry, India

Choolayil AC, Anandhan M, Elangovan N, et al. SAGE Publications. DIGITAL HEALTH. 2025;
Download PDF
Publication

Exploring the value of community engagement activities within a participatory action research study to improve care for people affected by skin neglected tropical diseases in Liberia

Lopez Piggott M, Zaizay Z, Dean L, et al. Springer Science and Business Media LLC. Research Involvement and Engagement. 2025;
Download PDF
Publication

Time to consider doxycycline in the standard treatment of lymphatic filariasis? Emerging evidence on use of doxycycline as an adjunct to hygiene protocols

Kakakhel MZJ, Rath S, Sheraz M, et al. Springer Science and Business Media LLC. Tropical Medicine and Health. 2025;
Download PDF
Publication

Persistent lymphatic filariasis transmission seven years after validation of elimination as a public health problem: a cross-sectional study in Tonga

Lawford HL, Tukia ‘, Takai J, et al. Elsevier BV. The Lancet Regional Health - Western Pacific. 2025;
Download PDF
Publication

Neglected Tropical Diseases Remain a Considerable Public Health Challenge in West Africa

Ramsay A, Kamau EM. MDPI AG. Tropical Medicine and Infectious Disease. 2025; 10 (3) : 13.
Download PDF
Publication

Safety and effectiveness of triple-drug therapy with ivermectin, diethylcarbamazine, and albendazole in reducing lymphatic filariasis prevalence and clearing circulating filarial antigens in Mombasa, Kenya

Khaemba C, Njenga SM, Omondi WP, et al. Springer Science and Business Media LLC. Infectious Diseases of Poverty. 2025;
Download PDF
Publication

Validation of routine lymphatic filariasis morbidity surveillance in the Upper West Region, Ghana

Simpson H, Agyabeng K, Alomatu B, et al. PLOS Global Public Health. 2025;
Publication

The Utility of Infectious Disease Prevalence Studies to Inform Public Health Decision-Making in the Samoan Islands: A Systematic Review

Martin BM, Brown A, Amosa-Lei Sam F, et al. MDPI AG. Tropical Medicine and Infectious Disease. 2025; 10 (3) : 71.
Download PDF
Publication

Recurrence of microfilaraemia after triple-drug therapy for lymphatic filariasis in Samoa: Recrudescence or reinfection?

Mayfield HJ, Muttucumaru R, Sartorius B, et al. Elsevier BV. International Journal of Infectious Diseases. 2025;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 3
  • Next page ››
Subscribe to Lymphatic filariasis (Elephantiasis)

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites NTD:

  • Infolep

© 2025 InfoNTD